These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 14598147)

  • 61. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hilar cholangiocarcinoma: preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence.
    Yin LL; Song B; Xu J; Li YC
    Chin Med J (Engl); 2007 Apr; 120(8):636-42. PubMed ID: 17517176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System.
    Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Nakanuma Y; Uesaka K
    J Gastrointest Surg; 2020 Apr; 24(4):786-795. PubMed ID: 31012045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
    Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
    J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.
    Isa T; Kusano T; Shimoji H; Takeshima Y; Muto Y; Furukawa M
    Am J Surg; 2001 Jun; 181(6):507-11. PubMed ID: 11513774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth.
    Hai S; Kubo S; Uenishi T; Yamamoto T; Tanaka H; Shuto T; Takemura S; Hirohashi K
    Hepatogastroenterology; 2005; 52(62):374-7. PubMed ID: 15816439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct.
    Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T
    Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820
    [No Abstract]   [Full Text] [Related]  

  • 75. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.
    Uno M; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surg Today; 2012 Dec; 42(12):1189-94. PubMed ID: 22350300
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
    Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
    Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
    Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
    Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
    Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
    Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.